Alyce Arnick Lichaa

Alyce Arnick Lichaa is an accomplished finance professional with extensive experience in financial planning and analysis across various organizations. Currently serving as the Director of Financial Planning and Analysis at Eikon Therapeutics, Alyce previously held senior leadership roles at ReCode Therapeutics and Alector, where responsibilities included leading forecasting and budgeting processes, financial modeling, and managing a significant annual budget. Alyce's background includes vital contributions to strategic financial initiatives during key phases of company growth, including roles at Allogene Therapeutics, RGP, and McKesson, where skills in financial forecasting, reporting, and operations management were developed. Alyce holds an MBA from Texas McCombs School of Business and a Bachelor of Arts in English Language and Literature from Colorado State University.